MedPath

NLR and PLR Levels Following iPACK Block in Hip Arthroplasty

Phase 4
Recruiting
Conditions
Hip Arthropathy
Hip Osteoarthritis
Hip Pain Chronic
Interventions
Drug: 0.9% Sodium Chloride Injection
Registration Number
NCT07023107
Lead Sponsor
Poznan University of Medical Sciences
Brief Summary

Effect of PENG block on NLR and PLR following hip arthroplasty

Detailed Description

The NLR is a sensitive indicator of inflammation confirmed in numerous studies and has a predictive and prognostic value. NLR is a cheap, simple, fast-acting, readily available stress and inflammation parameter with high sensitivity and low specificity. Dynamic changes in the NLR precede the clinical state by several hours and may alert clinicians to the ongoing pathological process early. NLR is a new promising marker of cellular immune activation, an important indicator of stress and systemic inflammation. It opens a new dimension for clinical medicine, enabling a better understanding of the biology of inflammation, the linkage and antagonism between innate and adaptive immunity, and their clinical consequences for health and disease.

NLR is affected not only by surgical trauma but also by the method of anesthesia. In recent years, the influence of regional anesthesiology on reducing the inflammatory response after surgical procedures has been emphasized. However, there have been very few studies evaluating the effect of various methods of anesthesia on the NLR.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Patients with ASA classification I-III
  • Aged 60-100 years
  • Who will be scheduled for hip arthroplasty under spinal anesthesia
Exclusion Criteria
  • Patients who have a history of bleeding diathesis
  • Take anticoagulant therapy
  • History of chronic pain before surgery
  • Multiple trauma
  • patients unable to assess their pain (dementia)
  • patients operated under general anesthesia
  • patients having an infection in the region of the procedure
  • the patient who does not accept the procedure

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Sham blocks0.9% Sodium Chloride InjectionPENG block with 20ml of 0.9% sodium chloride
PENG blockRopivacaine 0.2% Injectable SolutionPENG block with 20ml 0f 0.2% ropivacaine
Primary Outcome Measures
NameTimeMethod
Neutrophil-to-lymphocyte ratio12 hours after surgery

Neutrophil to lymphocyte ratio (NLR) is used as a marker of subclinical inflammation. It is calculated by dividing the number of neutrophils by number of lymphocytes, usually from peripheral blood sample, but sometimes also from cells that infiltrate tissue, such as tumor.

Secondary Outcome Measures
NameTimeMethod
PLR48 hours after surgery

Platelet-to-lymphocyte ratio

NLR48 hours after surgery

Neutrophil-to-lymphocyte ratio

first need of opiate48 hours after procedure

Time after surgery when the patient needs opiate for the first time

Opioid Consumption48 hours after surgery

Total opiate consumption after surgery

Pain score24 hours after surgery

NRS (Numerical Rating Scale) - ranging from 0 to 10, where 0 represents "no pain" and 10 represents the "worst pain imaginable"

Trial Locations

Locations (1)

Poznan University of Medical Sciences

🇵🇱

Poznań, Poland

Poznan University of Medical Sciences
🇵🇱Poznań, Poland
Malgorzata Reysner, M.D. Ph.D.
Contact
+48 608762068
mreysner@ump.edu.pl

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.